Business Context and Reporting Period
Company: The Scotts Miracle-Gro Company (SMG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and six months ended March 29, 2025 (Fiscal Q2 2025)
Business Overview: SMG manufactures and markets lawn and garden care products (U.S. Consumer and Other segments) and indoor/hydroponic gardening products (Hawthorne segment). The business is highly seasonal, with over 75% of annual net sales occurring in the second and third fiscal quarters.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Mar 29, 2025 |
Three Months Ended Mar 30, 2024 |
Six Months Ended Mar 29, 2025 |
Six Months Ended Mar 30, 2024 |
|---|---|---|---|---|
| Net Sales | $1,421.0 | $1,525.4 | $1,837.8 | $1,935.8 |
| Gross Margin | $547.9 (38.6%) | $463.7 (30.4%) | $642.7 (35.0%) | $525.9 (27.2%) |
| Income from Operations | $344.7 | $272.1 | $293.7 | $224.8 |
| Net Income | $217.5 | $157.5 | $148.0 | $77.0 |
| Diluted EPS | $3.72 | $2.74 | $2.53 | $1.34 |
| Operating Cash Flow | — | — | $(257.2) | $(39.0) |
| Cash & Equivalents | $16.9 | $65.1 | $16.9 | $65.1 |
| Total Debt | $2,563.1 | $2,837.2 | $2,563.1 | $2,837.2 |
Note: Operating cash flow for the six months ended March 29, 2025, was negative $257.2 million, primarily due to seasonal working capital builds (inventory and receivables).
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.8% (Q/Q) and 5.1% (YTD) compared to the prior year. This was driven by lower sales volume in the U.S. Consumer segment (fertilizer, grass seed, controls) and a significant 50.8% volume decline in the Hawthorne segment due to cannabis market oversupply and the discontinuation of third-party product distribution.
- Margin Expansion: Gross margin rate improved significantly to 38.6% (Q/Q) and 35.0% (YTD) from 30.4% and 27.2% respectively. This was driven by lower material costs, favorable product mix, and a substantial reduction in impairment and restructuring charges.
- Restructuring Charges: Total impairment, restructuring, and other charges dropped to $18.0 million (Q/Q) and $39.6 million (YTD) from $77.0 million and $64.1 million in the prior year periods. The prior year included significant inventory write-downs and facility closure costs in the Hawthorne segment.
- Profitability: Despite lower sales, Net Income increased 38.1% (Q/Q) and 92.2% (YTD) due to margin improvements and lower non-operating expenses.
Outlook, Risks, and Contingencies
- Hawthorne Segment Outlook: Management expects the oversupply of cannabis and lower wholesale prices to continue adversely impacting the Hawthorne segment. The segment has shifted focus to its Signature brands, resulting in lower sales volume but improved profitability.
- Liquidity and Debt Covenants:
- Total indebtedness is $2,545.0 million. The company does not have sufficient cash on hand to repay this in the event of a default.
- Leverage Ratio: 4.41 (within the 5.25 covenant limit for Q2 2025).
- Fixed Charge Coverage: 1.45 (above the 1.00 minimum).
- Interest Coverage: 4.17 (above the 2.00 minimum for Senior Notes).
- Contingency Planning: Management has contemplated alternative plans for potential covenant non-compliance, including further restructuring, cash management strategies, lender discussions, or equity issuance. There is no assurance these plans will be successful.
- Legal Proceedings: The company is defending against consolidated securities class actions alleging misstatements regarding inventories and sales, as well as shareholder derivative lawsuits. Management believes these claims are without merit.
Key Investor Verification Points
- Seasonal Cash Flow: Verify the sustainability of negative operating cash flow ($257.2M YTD) driven by seasonal inventory builds and receivables sales timing.
- Hawthorne Recovery: Assess the duration and severity of the cannabis market oversupply and its impact on the Hawthorne segment's long-term revenue trajectory.
- Debt Covenant Compliance: Monitor the leverage ratio closely as it approaches the 5.25 threshold for Q2 2025 and tightens to 5.00 in Q3 2025.
- Restructuring Completion: Confirm that the significant reduction in restructuring charges reflects the completion of major cost-cutting initiatives rather than a deferral of necessary actions.
- Legal Exposure: Track developments in the securities class action lawsuits regarding inventory and sales disclosures.